(VFVA) Vanguard U.S. Value Factor - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US9219358051 • Mid-Cap Value
VFVA: Stocks, Equities, US, Companies
The Vanguard U.S. Value Factor ETF (BATS: VFVA) is designed to capture the potential of value investing in the U.S. equity market by targeting companies with lower valuations relative to their fundamental worth. The funds strategy revolves around identifying stocks where the market price lags behind intrinsic value, often measured through metrics like price-to-earnings (P/E) or price-to-book (P/B) ratios. By focusing on these undervalued securities, the ETF aims to deliver higher returns over the long term compared to the broader U.S. equity market.
As a mid-cap value ETF, VFVA primarily invests in mid-sized U.S. companies, which are typically more established than small-caps but still offer growth potential. The funds portfolio is diversified across various sectors, though it may lean toward industries where value investing is more prevalent, such as financials, industrials, and consumer staples. Under normal market conditions, at least 80% of the funds assets are allocated to U.S. securities, providing a high level of exposure to domestic economic trends.
With assets under management (AUM) of $836.79M USD, VFVA operates with a relatively modest size compared to some of its peers, which can provide flexibility in navigating the value segment of the market. The funds expense ratio is competitive, aligning with Vanguards reputation for cost-efficient investment products. This approach not only enhances accessibility for retail investors but also supports the funds goal of delivering value to its shareholders over time.
Looking ahead, the future outlook for VFVA hinges on the cyclical nature of value investing. As interest rates rise and inflation pressures ease, value stocks, particularly those in financials and industrials, may regain favor. Additionally, the funds focus on mid-cap companies could benefit from a potential rotation out of growth stocks into more stable, cash-flow-rich businesses. However, the persistent dominance of growth-oriented investing in the U.S. market could pose a challenge. Over the long term, VFVAs success will depend on its ability to consistently identify undervalued companies and adapt to shifting market dynamics, much like the principles outlined by Aswath Damodaran in his valuation frameworks.
Additional Sources for VFVA ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
VFVA ETF Overview
Market Cap in USD | 664m |
Category | Mid-Cap Value |
TER | 0.13% |
IPO / Inception | 2018-02-13 |
VFVA ETF Ratings
Growth Rating | 73.6 |
Fundamental | - |
Dividend Rating | 72.3 |
Rel. Strength | -12.1 |
Analysts | - |
Fair Price Momentum | 102.49 USD |
Fair Price DCF | - |
VFVA Dividends
Dividend Yield 12m | 2.60% |
Yield on Cost 5y | 6.18% |
Annual Growth 5y | 12.30% |
Payout Consistency | 99.0% |
VFVA Growth Ratios
Growth Correlation 3m | -90.6% |
Growth Correlation 12m | 28.4% |
Growth Correlation 5y | 88% |
CAGR 5y | 17.84% |
CAGR/Max DD 5y | 0.74 |
Sharpe Ratio 12m | -0.15 |
Alpha | -13.32 |
Beta | 0.887 |
Volatility | 41.29% |
Current Volume | 69.1k |
Average Volume 20d | 44.1k |
As of April 28, 2025, the stock is trading at USD 107.33 with a total of 69,138 shares traded.
Over the past week, the price has changed by +5.70%, over one month by -7.44%, over three months by -13.15% and over the past year by -3.91%.
Yes. Based on ValueRay Analyses, Vanguard U.S. Value Factor (BATS:VFVA) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 73.60 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VFVA as of April 2025 is 102.49. This means that VFVA is currently overvalued and has a potential downside of -4.51%.
Vanguard U.S. Value Factor has no consensus analysts rating.
According to ValueRays Forecast Model, VFVA Vanguard U.S. Value Factor will be worth about 115.8 in April 2026. The stock is currently trading at 107.33. This means that the stock has a potential upside of +7.92%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 115.8 | 7.9% |